MRVI R&D to Revenue
Maravai Lifesciences Holdings Inc · R&D to Revenue
MRVI R&D to Revenue
Latest reported12.56%period ending
MRVI FY R&D/Revenue (3.63% → 12.56%)
Latest values, visible window
High-resolution chart · PNG
MRVI r&d to revenue history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D to Revenue |
|---|---|
| 12.5593% | |
| 7.4159% | |
| 5.9804% | |
| 2.0803% | |
| 1.9042% | |
| 3.2749% | |
| 2.5339% | |
| 3.6331% |